Related references
Note: Only part of the references are listed.GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
Da Young Oh et al.
CELL (2010)
Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)
Shinichi Oikawa et al.
ATHEROSCLEROSIS (2009)
Eicosapentaenoic acid increases cytochrome P-450 2J2 gene expression and epoxyeicosatrienoic acid production via peroxisome proliferator-activated receptor gamma in endothelial cells
Dahai Wang et al.
JOURNAL OF CARDIOLOGY (2009)
Eicosapentaenoic Acid Improves Imbalance between Vasodilator and Vasoconstrictor Actions of Endothelium-Derived Factors in Mesenteric Arteries from Rats at Chronic Stage of Type 2 Diabetes
Takayuki Matsumoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
Carl J. Lavie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Meta-Analysis of the Relationship Between Non-High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
Jennifer G. Robinson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target
Hitoshi Shimano et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2008)
Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men - A cross-sectional study
Akira Sekikawa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
Short duration of reactive hyperemia in the forearm of subjects with multiple cardiovascular risk factors
Y Ishibashi et al.
CIRCULATION JOURNAL (2006)
Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes
MS Bitar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Statins promote potent systemic antioxidant effects through specific inflammatory pathways
MH Shishehbor et al.
CIRCULATION (2003)
Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients
T Inoue et al.
ATHEROSCLEROSIS (2002)
n-3 polyunsaturated fatty acids, fish, and nonfatal acute myocardial infarction
A Tavani et al.
CIRCULATION (2001)
A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans
Y Higashi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Share Paper
